NCT07159074

Repurposing Tilmanocept for Cardiac Sarcoidosis

Repurposing Tc 99m Tilmanocept Imaging for Cardiac Sarcoidosis

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 15 (estimated)
• Sponsor: Duke University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to see if Tc 99m Tilmanocept SPECT/CT imaging can be used to identify cardiac sarcoidosis.

Conditions

• Cardiac Sarcoidosis

Interventions

Type	Name	Description
DRUG	Tc 99m tilmanocept	150 mcg containing 10 mCi of Tc 99m tilmanocept will be administered through an IV route of injection. SPECT-CT imaging will then be performed.
DRUG	Tc 99m tilmanocept	150 mcg containing 10 mCi of Tc 99m tilmanocept will be administered through a SC route of injection. SPECT-CT imaging will then be performed.

Timeline

• Start date: 2025-09-17
• Primary completion: 2026-12-01
• Completion: 2026-12-31
• First posted: 2025-09-08
• Last updated: 2026-03-27

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study